Tellgen Corporation

Shenzhen Stock Exchange 300642.SZ

Tellgen Corporation Net Income for the year ending December 31, 2023: USD 12.59 M

Tellgen Corporation Net Income is USD 12.59 M for the year ending December 31, 2023, a -30.35% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Tellgen Corporation Net Income for the year ending December 31, 2022 was USD 18.08 M, a -28.69% change year over year.
  • Tellgen Corporation Net Income for the year ending December 31, 2021 was USD 25.35 M, a 37.27% change year over year.
  • Tellgen Corporation Net Income for the year ending December 31, 2020 was USD 18.47 M, a -18.09% change year over year.
  • Tellgen Corporation Net Income for the year ending December 31, 2019 was USD 22.55 M, a 9.45% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
SV Wall Street
Shenzhen Stock Exchange: 300642.SZ

Tellgen Corporation

CEO Mr. Jian Er Yao
IPO Date April 21, 2017
Location China
Headquarters Building 1
Employees 574
Sector Healthcare
Industries
Biotechnology 3D Printing Cleaning Supplies Cosmetics Glass Personal Care Pharmaceuticals Vaccines
Description

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email